These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30458231)

  • 1. Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice.
    Spiller KJ; Khan T; Dominique MA; Restrepo CR; Cotton-Samuel D; Levitan M; Jafar-Nejad P; Zhang B; Soriano A; Rigo F; Trojanowski JQ; Lee VM
    Neurobiol Dis; 2019 Apr; 124():133-140. PubMed ID: 30458231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis.
    Hur SK; Hunter M; Dominique MA; Farag M; Cotton-Samuel D; Khan T; Trojanowski JQ; Spiller KJ; Lee VM
    Acta Neuropathol Commun; 2022 May; 10(1):75. PubMed ID: 35568882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis of aggrecan-positive perineuronal nets surrounding motor neurons by reactive microglia expressing MMP-9 in TDP-43
    Cheung SW; Willis EF; Simmons DG; Bellingham MC; Noakes PG
    Neurobiol Dis; 2024 Oct; 200():106614. PubMed ID: 39067491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise training induces mild skeletal muscle adaptations without altering disease progression in a TDP-43 mouse model.
    Tsitkanou S; Lindsay A; Abbott G; Foletta V; Walker AK; Russell AP; Della Gatta PA
    J Appl Physiol (1985); 2024 Sep; 137(3):728-745. PubMed ID: 39008617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy.
    Tsitkanou S; Della Gatta PA; Abbott G; Wallace MA; Lindsay A; Gerlinger-Romero F; Walker AK; Foletta VC; Russell AP
    Neurobiol Dis; 2022 Jan; 162():105559. PubMed ID: 34774794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.
    Kaplan A; Spiller KJ; Towne C; Kanning KC; Choe GT; Geber A; Akay T; Aebischer P; Henderson CE
    Neuron; 2014 Jan; 81(2):333-48. PubMed ID: 24462097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD.
    Luan W; Wright AL; Brown-Wright H; Le S; San Gil R; Madrid San Martin L; Ling K; Jafar-Nejad P; Rigo F; Walker AK
    Mol Psychiatry; 2023 Jun; 28(6):2445-2461. PubMed ID: 37012334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
    Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
    Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
    Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
    Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9.
    Morisaki Y; Niikura M; Watanabe M; Onishi K; Tanabe S; Moriwaki Y; Okuda T; Ohara S; Murayama S; Takao M; Uchida S; Yamanaka K; Misawa H
    Sci Rep; 2016 Jun; 6():27354. PubMed ID: 27264390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
    Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
    Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.
    Williamson MG; Finelli MJ; Sleigh JN; Reddington A; Gordon D; Talbot K; Davies KE; Oliver PL
    Hum Mol Genet; 2019 Nov; 28(21):3584-3599. PubMed ID: 31642482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
    Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
    Sun X; Song J; Huang H; Chen H; Qian K
    Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.
    Hatzipetros T; Bogdanik LP; Tassinari VR; Kidd JD; Moreno AJ; Davis C; Osborne M; Austin A; Vieira FG; Lutz C; Perrin S
    Brain Res; 2014 Oct; 1584():59-72. PubMed ID: 24141148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
    Fallini C; Bassell GJ; Rossoll W
    Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.